FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/102790 [Registered on: 02/02/2026] Trial Registered Prospectively
Last Modified On: 01/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cohort Study 
Study Design  Other 
Public Title of Study   To observe the level of titanium ions released before and after the placement of dental implanys in saliva 
Scientific Title of Study   Assessing Titanium ion release in saliva after placement of dental implant: A Prospective cohort Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sangeeta Gupta 
Designation  MDS Student 
Affiliation  Panjab University 
Address  Department of Periodontics Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital Sector 25,Panjab university

Chandigarh
CHANDIGARH
160025
India 
Phone  6283683050  
Fax    
Email  sangeetagupta.07sg@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ashish Jain  
Designation  Professor and Head 
Affiliation  Panjab University 
Address  Department of Periodontics Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital Sector 25,Panjab university

Chandigarh
CHANDIGARH
160025
India 
Phone  9888000444  
Fax    
Email  ajain.pu@gmail.com   
 
Details of Contact Person
Public Query
 
Name  Dr Gurparkash Singh Chahal 
Designation  Assistant Professor 
Affiliation  Panjab University 
Address  Department of Periodontics Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital Sector 25,Panjab university

Chandigarh
CHANDIGARH
160025
India 
Phone  9872978629  
Fax    
Email  gpchahal29@gmail.com  
 
Source of Monetary or Material Support  
NIL,Dr Harvansh Singh Judge Institute of Dental Sciences & Hospital, Sector- 25, Chandigarh, 160014  
 
Primary Sponsor  
Name  Dr Sangeeta Gupta 
Address  Department of periodontology Dr Harvansh Singh Judge Institute of Dental Sciences & Hospital 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
Dr Gurparkash Singh Chahal  Department of periodontology Dr Harvansh Singh Judge Institute of Dental Sciences & Hospital 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sangeeta Gupta  Dr Harvansh Singh Judge Institute of Dental Sciences & Hospital  Room no 108, Dept of Periodontology, Sector- 25, chandigarh
Chandigarh
CHANDIGARH 
6283683050

sangeetagupta.07sg@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Panjab University Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Partially edentulous patients 
Patients  (1) ICD-10 Condition: K069||Disorder of gingiva and edentulousalveolar ridge, unspecified, (2) ICD-10 Condition: K069||Disorder of gingiva and edentulousalveolar ridge, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Male or female
Subject equal or above 18 years
Systemically healthy patients for implants
Presence of edentulous site in mouth that is indicated for implant surgery
Voluntarily signing of informed consent
Subject commitment to the study and follow up visits. 
 
ExclusionCriteria 
Details  • No prior placement of dental implant.
• Pregnant/lactating women
• Smokers, tobacco chewers, alcohol or drug addicts
• Systemic diseases or conditions such as metabolic diseases, bone and hematological diseases, immunodeficiency, uncontrolled diabetes mellitus, kidney failure, tumor or radiation in head and neck area or any other disease contraindicating implant placement
• Patients unwilling to complete the treatment protocol.
• Patient with history of allergic tendencies.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Titanium levels  Before implant placement
1 week, 1 month, 3 months, 6 months after implant placement 
 
Secondary Outcome  
Outcome  TimePoints 
•Modified Plaque Index,
•Modified Gingival Index,
•Bleeding on Probing,
•Probing depth and
•Clinical attachment loss (CAL)
 
Before implant placement
1 week, 1 month, 3 months and 6 months after implant placement 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [sangeetagupta.07sg@gmail.com].

  6. For how long will this data be available start date provided 01-07-2025 and end date provided 01-08-2028?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   Patients will be recruited based on inclusion and exclusion criteria and explained about the nature of the study, the outcome of it, following which a verbal and written consent will be obtained. A complete history and full mouth clinical examination will be performed followed by full mouth SRP by manual and ultrasonic scalers. Single stage Implant placement will be done.
Saliva sample will be collected before implant placement then 7th day, 1 month, 3 months and 6 months after implant placement. 
 
Close